What are the benefits and risks of using azathioprine in oncology patients?
Fuente:
Zenodo
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2026
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866901696898138112 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Azathioprine is used as an immunosuppressant with known oncogenic risks, notably for lymphomas and skin cancers, while direct oncological benefits remain underexplored. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20159373 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What are the benefits and risks of using azathioprine in oncology patients? Tripdatabase azathioprine oncology benefits risks immunosuppressant cancer treatment side effects complications pharmacology Azathioprine is used as an immunosuppressant with known oncogenic risks, notably for lymphomas and skin cancers, while direct oncological benefits remain underexplored. |
| title | What are the benefits and risks of using azathioprine in oncology patients? |
| topic | azathioprine oncology benefits risks immunosuppressant cancer treatment side effects complications pharmacology |
| url | https://doi.org/10.5281/zenodo.20159373 |